Description of Research Expertise:
Pulmonary Hypertension
Heart Failure with Reduced Ejection Fraction
Heart Failure with Preserved Ejection Fraction
Hemodynamics
Cardiopulmonary Exercise Testing
Biomarkers
Echocardiography
Right Ventricular Failure
Selected Publications:
Ruth Benjamin K, Bilchick Kenneth C, Mysore Manu M, Mwansa Hunter, Harding William C, Kwon Younghoon, Kennedy Jamie L W, Mazurek Jeremy A, Mihalek Andrew D, Smith LaVone A, Mejia-Lopez Eliany, Parker Alex M, Welch Timothy S, Mazimba Sula: Increased Pulmonary-Systemic Pulse Pressure Ratio Is Associated With Increased Mortality in Group 1 Pulmonary Hypertension. Heart, lung & circulation : 2018.
Birati Edo Y, Hanff Thomas C, Maldonado Dawn, Grandin E Wilson, Kennel Peter J, Mazurek Jeremy A, Vorovich Esther, Seigerman Matthew, Howard Jessica L L, Acker Michael A, Naka Yoshifumi, Wald Joyce, Goldberg Lee R, Jessup Mariell, Atluri Pavan, Margulies Kenneth B, Schulze P Christian, Rame J Eduardo: Predicting Long Term Outcome in Patients Treated With Continuous Flow Left Ventricular Assist Device: The Penn-Columbia Risk Score. Journal of the American Heart Association 7 (6): 2018.
Han Yuchi, Forfia Paul R, Vaidya Anjali, Mazurek Jeremy A, Park Myung H, Ramani Gautam, Chan Stephen Y, Waxman Aaron B: Rationale and design of the ranolazine PH-RV study: a multicentred randomised and placebo-controlled study of ranolazine to improve RV function in patients with non-group 2 pulmonary hypertension. Open heart 5 (1): e000736,2018.
Gopal Dipika J, Hanff Thomas C, Mazurek Jeremy A, Grandin Wilson E, Howard Jessica, Forde-McLean Rhondalyn, Wald Joyce, King Kathie, Acker Michael A, Goldberg Lee R, Jessup Mariell, Atluri Pavan, Margulies Kenneth B, Rame Eduardo J, Birati Edo Y: Prognostic Implications of Changes in Albumin Following Left Ventricular Assist Device Implantation in Patients With Severe Heart Failure. The American Journal of Cardiology 120 (11): 2003-2007,2017.
Adusumalli Srinath, Mazurek Jeremy A: Pulmonary Hypertension Due to Left Ventricular Cardiomyopathy: Is it the Result or Cause of Disease Progression? Current Heart Failure Reports 14 (6): 507-513,2017.
Mazurek Jeremy A, Horne Benjamin D, Saeed Wajeeha, Sardar Muhammad R, Zolty Ronald: Galectin-3 Levels Are Elevated and Predictive of Mortality in Pulmonary Hypertension. Heart, Lung & Circulation 26 (11): 1208-1215,2017.
Mazure JA, Horne BD, Saeed W, Sardar MR, Zolty R: Galectin-3 Levels are elevated and Predictive of Mortality in Pulmonary Hypertension Heart Lung Circ (1-19): 2017.
Menachem JN, Golbus JR, Molina M, Mazurek JA, Hornsby N, Atluri P, Fuller S, Birati EY, Kim YY, Goldberg LR, Wald JW: Successful Cardiac Transplantation Outcomes in Patients with Adult Congenital Heart Disease Heart (1449-1454): 2017.
Gopal DJ, Hanff TC, Mazurek, JA, Grandin WE, Howard J, Forde-McLean R, Wald J, King K, Acker MA, Goldberg LR, Jessup M, Atluri P, Margulies KB, Rame EJ, Birati EY.: Prognostic Implications of Changes in Albumin Following Left Ventricular Assist Device Implantation in Patients with Severe Heart Failure. Am J Cardiol (10.1016): 2017.
Mazurek Jeremy A, Vaidya Anjali, Mathai Stephen C, Roberts Justin D, Forfia Paul R: Follow-up tricuspid annular plane systolic excursion predicts survival in pulmonary arterial hypertension. Pulmonary Circulation 7 (2): 361-371,2017.
View all publications